Highlighting Quality of Life Considerations for MZL Treatment
Cancer Network,
Juan Alderuccio, MD, discussed treatment strategies for MZL, particularly as they relate to quality of life, and the role of…
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma
Overview of attention for article published in Blood Advances, March 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
High Attention Score compared to outputs of the same age and source (85th percentile)
Readers on
- mendeley
- 35 Mendeley
